SPDR S&P Biotech ETF
427 hedge funds and large institutions have $4.42B invested in SPDR S&P Biotech ETF in 2018 Q4 according to their latest regulatory filings, with 92 funds opening new positions, 113 increasing their positions, 149 reducing their positions, and 91 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
24% less repeat investments, than reductions
Existing positions increased: 113 | Existing positions reduced: 149
30% less funds holding in top 10
Funds holding in top 10: 20 → 14 (-6)
46% less call options, than puts
Call options by funds: $1.01B | Put options by funds: $1.89B
Holders
427
Holding in Top 10
14
Calls
$1.01B
Puts
$1.89B
Top Buyers
| 1 | +$358M | |
| 2 | +$165M | |
| 3 | +$45.8M | |
| 4 |
Jane Street
New York
|
+$44.5M |
| 5 |
Morgan Stanley
New York
|
+$25.2M |
Top Sellers
| 1 | -$160M | |
| 2 | -$132M | |
| 3 | -$82.9M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$58.5M |
| 5 |
AssetMark Inc
Concord,
California
|
-$58.4M |